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Introduction
PFAPA syndrome is an auto-inflammatory disease
(AID), characterized by recurrent fever aphtosis, pharyn-
gitis and cervical adenitis. A familial predominance has
been observed and variants in the NLRP3 gene were
recently found in several patients. The NLRP3 Q703K
variant was described so far in CAPS patient and in
healthy carriers.
Objectives
To describe the different phenotypes of patients with
recurrent fever and Q703K variant
Methods
In patients presenting to our consultation with recurrent
fever suspected to be auto-inflammatory, we screened
genomic DNA by PCR and sequenced for genetic var-
iants of NLRP3 genes. The symptoms, treatment,
response to treatment and family history of the patients
with the variant Q703K have been retrospectively
extracted and described.
Results
We found the NLRP3 variant Q703K in 13 patients. Ten
were PFAPA patients among 97 from our cohort; one
had a CAPS phenotype and two an undefined autoin-
flammatory disease (UAID): 9 boys and 4 girls with a
median age of 18 months at disease onset. Family history
was positive in 6 PFAPA and one UAID patients. For
PFAPA, the median duration of fever was 4 days; the
median interval was 4 weeks. Pharyngitis and cervical
adenitis was always present in 6 patients. Aphtosis was
found only in 1 patient in every episode. 5 patients
expressed abdominal pain that accompanied most fever
episodes. 1 patient showed sometimes arthralgia, 2
patients had headaches in most episodes and one patient
had once a cutaneous rash. 5 out of 7 patients treated by
corticosteroids responded promptly. In the other two
patients two doses were often necessary. 3 patients
underwent tonsillectomy: one with no effect, in 2 the
fever episodes resolved but one patient had persistent
episodes of aphtosis. In 4 patients genomic sequencing of
the parents was done; one parent positive for Q703K had
a history of recurrent febrile episodes, but the 3 other
parents did not present a history of recurrent fever epi-
sodes nor recurrent pharyngitis nor tonsillectomy. The
patient with CAPS phenotype presented with urticarial
rash, partial deafness, arthralgias and elevated inflamma-
tory parameters, and responded well to IL-1 blocking
agents. One patient with UAID presented recurrent fever
episodes with neurological symptoms (hypotonia, bulging
fontanelle, loss of contact) and high inflammatory mar-
kers, and the second with fever flares and angioedema. In
one UAID and two PFAPA patients another heterozygous
variant in the MEFV gene was found.
Conclusion
We report 13 patients positive for the NLRP3 Q703K
variant and presenting different phenotypes, mainly
PFAPA syndrome. The role of this variant in the clinical
manifestations of our patients is challenged by the nega-
tive history for fever syndromes in the Q703K+ PFAPA
parents. The presence of a second variant in a gene
involved in recurrent fever syndromes in 3 of our 13
patients suggests that another gain-of-function mutation
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